The estimated Net Worth of Peter C Monson is at least $26.7 Tysiąc dollars as of 8 March 2007. Peter Monson owns over 9,750 units of Psychemedics stock worth over $26,731 and over the last 21 years Peter sold PMD stock worth over $0.
Sign up
Peter Monson PMD stock SEC Form 4 insiders trading
Peter has made over 4 trades of the Psychemedics stock since 2007, according to the Form 4 filled with the SEC. Most recently Peter exercised 9,750 units of PMD stock worth $140,400 on 8 March 2007.
The largest trade Peter's ever made was exercising 9,750 units of Psychemedics stock on 8 March 2007 worth over $140,400. On average, Peter trades about 3,229 units every 1 days since 2004. As of 8 March 2007 Peter still owns at least 11,750 units of Psychemedics stock.
You can see the complete history of Peter Monson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Peter Monson's mailing address?
Peter's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 1280 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138.
Insiders trading at Psychemedics
Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen oraz Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.
What does Psychemedics do?
psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics' clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.
What does Psychemedics's logo look like?
Complete history of Peter Monson stock trades at Psychemedics
Psychemedics executives and stock owners
Psychemedics executives and other stock owners filed with the SEC include:
-
Raymond Kubacki,
Chairman of the Board, President, Chief Executive Officer -
Raymond C. Kubacki,
Chairman, CEO & Pres -
Charles Doucot,
Executive Vice President -
Michael Schaffer,
Vice President - Laboratory Operations -
Charles M. Doucot IV,
Exec. VP -
Dr. Michael I. Schaffer Ph.D.,
VP of Laboratory Operations -
A. Clinton Allen,
Independent Director -
Fred Weinert,
Independent Director -
Walter Tomenson,
Independent Director -
Harry Connick,
Independent Director -
Patrick J. Kinney Jr.,
Sec. -
Sarah Ashby,
VP & Gen. Counsel -
Andrew Limbek,
VP of Fin. & Controller -
Annette Baumgartner,
Founder -
Dr. Werner A. Baumgartner Ph.D.,
Founder -
Peter Kamin,
Director -
Neil Lerner,
VP - Finance -
James V. Dyke,
Vice President - Sales -
Michael Weisenhoff,
-
Raymond J Ruddy,
Vice President/Controller -
Jonathan D Compton,
Vice President - Marketing -
William R Thistle,
Sr. VP and Gen. Counsel -
Peter C Monson,
VP, Treas., CFO & Asst. Sec. -
Jennifer Chmieleski,
Vice President, Controller -
Richard T Christoph,
10% owner -
William Dausey,
Vice President of Sales -
Robyn C Davis,
Director -
Andrew Reynolds,
Director -
Shannon Shoemaker,
Chief Revenue Officer -
Darius G Nevin,
Director -
Brian Hullinger,
President & CEO -
Daniella Mehalik,
Vice President - Finance